IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1 +$24.3M
2 +$22.7M
3 +$20.3M
4
PTCT icon
PTC Therapeutics
PTCT
+$14.6M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$8.84M

Top Sells

1 +$18.5M
2 +$18.4M
3 +$13.9M
4
COGT icon
Cogent Biosciences
COGT
+$12.1M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$12M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
101
Karyopharm Therapeutics
KPTI
$167M
$178K 0.04%
27,257
COGT icon
102
Cogent Biosciences
COGT
$6.04B
$162K 0.03%
11,280
-1,024,248
AIRS icon
103
AirSculpt Technologies
AIRS
$108M
$144K 0.03%
17,951
CMMB
104
Chemomab Therapeutics
CMMB
$11M
$140K 0.03%
53,262
-1
LYRA icon
105
Lyra Therapeutics
LYRA
$2.2M
$139K 0.03%
21,161
PMVP icon
106
PMV Pharmaceuticals
PMVP
$86.2M
$137K 0.03%
+97,500
MGNX icon
107
MacroGenics
MGNX
$120M
$135K 0.03%
80,071
SPRB
108
SPRUCE BIOSCIENCES INC
SPRB
$61.6M
$119K 0.02%
13,332
-1
AEMD icon
109
Aethlon Medical
AEMD
$2.33M
$115K 0.02%
15,366
VYNE icon
110
VYNE Therapeutics
VYNE
$19.5M
$97.1K 0.02%
290,000
JSPR icon
111
Jasper Therapeutics
JSPR
$37.2M
$59.8K 0.01%
25,107
TRAW icon
112
Traws Pharma
TRAW
$13.2M
$52.7K 0.01%
28,493
TOVX icon
113
Theriva Biologics
TOVX
$6.77M
$48.6K 0.01%
120,031
SYBX
114
DELISTED
Synlogic
SYBX
$34.5K 0.01%
20,422
NMRA icon
115
Neumora Therapeutics
NMRA
$520M
$22.7K ﹤0.01%
12,498
AMIX
116
Autonomix Medical
AMIX
$4.51M
$21.6K ﹤0.01%
20,000
RCUS icon
117
Arcus Biosciences
RCUS
$2.81B
-163,363
RVMD icon
118
Revolution Medicines
RVMD
$19.4B
0
SGMT icon
119
Sagimet Biosciences
SGMT
$183M
-11,984
ALNY icon
120
Alnylam Pharmaceuticals
ALNY
$42.3B
-56,594
ALT icon
121
Altimmune
ALT
$521M
0
APGE icon
122
Apogee Therapeutics
APGE
$4.68B
-232,047
BIIB icon
123
Biogen
BIIB
$27B
-21,516
BMY icon
124
Bristol-Myers Squibb
BMY
$125B
0
CMPS
125
Compass Pathways
CMPS
$789M
0